Principal Financial Group’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-661,883
| Closed | -$34.2M | – | 2600 |
|
|
2022
Q3 | $34.2M | Buy |
661,883
+107,583
| +19% | +$4.45M | 0.03% | 507 |
|
|
2022
Q2 | $13.7M | Buy |
554,300
+249,434
| +82% | +$5.5M | 0.01% | 1084 |
|
|
2022
Q1 | $7.64M | Buy |
304,866
+14,964
| +5% | +$421K | ﹤0.01% | 1508 |
|
|
2021
Q4 | $10.6M | Buy |
289,902
+276,152
| +2,008% | +$9.69M | 0.01% | 1360 |
|
|
2021
Q3 | $235K | Sell |
13,750
-2,227
| -14% | -$34.7K | ﹤0.01% | 2386 |
|
|
2021
Q2 | $214K | Sell |
15,977
-9,905
| -38% | -$244K | ﹤0.01% | 2457 |
|
|
2021
Q1 | $1.33M | Sell |
25,882
-903
| -3% | -$54.3K | ﹤0.01% | 1934 |
|
|
2020
Q4 | $1.66M | Buy |
26,785
+6,942
| +35% | +$397K | ﹤0.01% | 1840 |
|
|
2020
Q3 | $1.09M | Sell |
19,843
-120
| -0.6% | -$6.46K | ﹤0.01% | 1854 |
|
|
2020
Q2 | $1.15M | Buy |
19,963
+5,740
| +40% | +$312K | ﹤0.01% | 1807 |
|
|
2020
Q1 | $571K | Buy |
14,223
+468
| +3% | +$19.9K | ﹤0.01% | 1841 |
|
|
2019
Q4 | $544K | Buy |
+13,755
| New | +$242K | ﹤0.01% | 1935 |
|
|
2013
Q4 | – | Sell |
-11,815
| Closed | -$66K | – | 2317 |
|
|
2013
Q3 | $66K | Buy |
+11,815
| New | +$128K | ﹤0.01% | 2243 |
|
Other funds holding CCXI
Principal Financial Group's CCXI Position: Q4 2022 in Review
Principal Financial Group sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 661,883 shares — an estimated $34.2M sold.
Principal Financial Group first reported a position in CCXI in Q3 2013 and held it in 13 quarters. The position peaked at $34.2M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- Principal Financial Group reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- Principal Financial Group sold 661,883 ChemoCentryx, Inc. shares in Q4 2022, an estimated $34.2M.
- Principal Financial Group first reported a position in ChemoCentryx, Inc. in Q3 2013 and held it in 13 quarters.
- Principal Financial Group's ChemoCentryx, Inc. position peaked at $34.2M in Q3 2022.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on Principal Financial Group's 13F filing for Q4 2022, filed 9 Feb 2023.